The curious case of Covaxin royalties
ICMR’s contradictions and obfuscation on ownership of the vaccine’s intellectual property is not helping in the fight against COVID-…
COVID-19 Challenge 2021: How does the world overcome vaccine shortage
The pharmaceuticals industry must come together to ensure all adults are vaccinated against the novel coronavirus; …
Treasure and the tricks
Conserving genetic purity of 750 varieties of rice with limited resources like a small piece of land and no workforce is a major challenge. Debal …
Looming threat of a secretive trade pact
Trans-Pacific Partnership agreement will extend restrictive intellectual property laws globally
A monopoly like none other
An amendment to the Montreal Protocol without addressing IPR issues of HFOs would mean that the entire MAC sector would be at the mercy of three …
A victory and a retreat on CLs
Supreme Court upholds India's first compulsory licence but government baulks at giving the second
Patently hollow claims of the US
Global organisations and academics defend India’s IP laws and call for US to back off
Why scientists don’t back Novartis claim
As Novartis’ Indian patent case reaches end, a reminder of how scientists view unfair patents
Menacing US diplomacy
Specialist attachés are strenuously pushing maximalist intellectual property rules worldwide
WHOSE SEED IS IT ANYWAY?
The rich world’s mania for patenting seeds and pushing the UPOV agenda do not aid food security or biological diversity
Blacked out & hacked
The fight to protect Internet freedom turns into war of attrition as protests against US measures to curb piracy grow strident
Acta is trade terrorism
India’s generic medicines export faces a huge threat from the anti-counterfeiting law which creates barriers to global trade
Coronavirus vaccines: TRIPS waiver caught in WTO labyrinth
Little change in the position of countries opposing waiver of intellectual property rights; India-South Africa proposal being through hoops …
Ignore US bullying on IPRs
Countries should not be stampeded into changing laws by the USTR's arbitrary Special 301 report
The innovation WHO needs
The strategy to push public health, innovation and intellectual property is a tough challenge because of funding constraints
FARM IP, ENTER WIPO
Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO
Brickbats for compulsory licences
US criticises India and BRIC group for strengthening provisions on life-saving medicines
Crazy for GI? Think again
The protection of Geographical Indication is not a guarantee that the artisan or producer will benefit; traders can corner the premium
A rather ridiculous gap
Clothing giant Gap’s trademark infringement notice to an NGO selling products made from recycled waste is a curious case
The fine line for judges
Judges have recused themselves in a number of cases but there are no clear guidelines on what constitutes conflict of interest
NCD battle starts now
The UN agreement on non-communicable diseases will get snagged on the issue of intellectual property rights for drugs
Obama takes first dip
The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative
Access, yes. Sharing, no
The access and benefit-sharing protocol on biodiversity may do little to deter multinationals from grabbing the planet’s resources
European Parliament rejects Anti-Counterfeiting Trade Agreement
Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries
Act of omission
Public institutions do not seek permission from the biodiversity authority before genetically manipulating crops